LEXICON PHARMACEUTICALS, INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2024-06-30 was $1.00K.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2024-03-31 was $88.00K.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $73.00K, a 14.06% increase from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $64.00K.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $0.00.
- LEXICON PHARMACEUTICALS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $1.59M.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2025-12-31 | $73.00K 10-K · filed 2026-03-05 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $64.00K 10-K · filed 2026-03-05 | |
| 2024-06-30 | $1.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $88.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $0.00 10-K · filed 2026-03-05 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-11-13 | |
| 2021-12-31 | $1.59M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |